Handelsbanken Fonder AB Boosts Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Handelsbanken Fonder AB grew its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 10.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,302 shares of the biotechnology company’s stock after buying an additional 1,300 shares during the quarter. Handelsbanken Fonder AB’s holdings in Axon Enterprise were worth $3,695,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the company. HB Wealth Management LLC lifted its holdings in shares of Axon Enterprise by 3.9% in the 4th quarter. HB Wealth Management LLC now owns 1,139 shares of the biotechnology company’s stock worth $294,000 after buying an additional 43 shares during the period. UMB Bank n.a. lifted its holdings in shares of Axon Enterprise by 11.0% in the 4th quarter. UMB Bank n.a. now owns 444 shares of the biotechnology company’s stock worth $115,000 after buying an additional 44 shares during the period. CWM LLC lifted its holdings in shares of Axon Enterprise by 1.8% in the 3rd quarter. CWM LLC now owns 2,669 shares of the biotechnology company’s stock worth $531,000 after buying an additional 46 shares during the period. Lindbrook Capital LLC lifted its holdings in shares of Axon Enterprise by 43.3% in the 4th quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company’s stock worth $44,000 after buying an additional 52 shares during the period. Finally, Greenleaf Trust lifted its holdings in shares of Axon Enterprise by 3.6% in the 3rd quarter. Greenleaf Trust now owns 1,540 shares of the biotechnology company’s stock worth $306,000 after buying an additional 54 shares during the period. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Trading Up 1.3 %

Shares of NASDAQ:AXON opened at $306.24 on Friday. The business’s 50-day moving average is $302.78 and its 200 day moving average is $260.58. Axon Enterprise, Inc. has a 1 year low of $175.37 and a 1 year high of $329.87. The firm has a market capitalization of $23.11 billion, a P/E ratio of 133.15 and a beta of 0.93. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.00 and a quick ratio of 2.66.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.29. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The company had revenue of $432.14 million for the quarter, compared to analyst estimates of $418.97 million. On average, research analysts predict that Axon Enterprise, Inc. will post 2.44 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Robert W. Baird upped their target price on Axon Enterprise from $260.00 to $300.00 and gave the stock an “outperform” rating in a report on Thursday, February 22nd. Barclays upped their target price on Axon Enterprise from $296.00 to $308.00 and gave the stock an “overweight” rating in a report on Thursday, February 29th. JMP Securities upped their price objective on Axon Enterprise from $250.00 to $285.00 and gave the stock a “market outperform” rating in a research note on Tuesday, February 6th. Morgan Stanley upped their price objective on Axon Enterprise from $250.00 to $285.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 28th. Finally, William Blair restated an “outperform” rating on shares of Axon Enterprise in a research note on Wednesday. Two research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $312.64.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.